State and Local Stakeholders

FDA works closely with State and Local stakeholders to make available safe and effective medical countermeasures during public health emergencies. FDA also establishes policies to safeguard medical products from adulteration and prevent supplies from being disrupted during a naturally occurring public emergency or deliberate threat. 

• March 15, 2012, Recent Developments in FDA's Emergency Authority for Medical Countermeasures, from the Public Health Law Webinar Series
• February 2012, National Association of County & City Health Officials (NACCHO) Public Health Preparedness Summit 2012: Regroup, Refocus, Refresh: Sustaining Preparedness in an Economic Crisis
   
  * Improving a Path Forward: New Steps in Anthrax Planning, FDA Anthrax Preparedness / FDA Response Planning and Execution,² CAPT Carmen Maher, Acting Deputy Director,    FDA's Office of Counterterrorism and Emerging Threats, and LCDR Anthony (Tony) Garza, FDA Office of Countertorrorism and Emerging Threats
    
  * Intro to Medical Countermeasures Policy, Products, and Practice, FDA's Role in Medical Countermeasures--Current Issues and Challenges, Brooke Courtney, JD, MPH, Regulatory
   Counsel, FDA Office of Countertorrorism and Emerging Threats
   
• Public Health Preparedness Meetings
  

  * Follow-up Qs and As to 14 December 2010 Responders Meeting 

• ASPR Assistance to Federal/State/Local/Tribes
• Centers for Disease Control Assistance